Pharmaceutics International Inc – FDA 483, Mar 18, 2016
An FDA inspection of Pharmaceutics International Inc. in Hunt Valley, MD, a drug manufacturer, revealed significant deficiencies across multiple systems. Repeated observations included inadequate environmental controls and HVAC monitoring, insufficient cleaning validation and procedures, and critical failures in data integrity and quality control unit oversight. The firm also failed to thoroughly investigate discrepancies and maintain proper production documentation, indicating systemic issues in GMP compliance.
ID · 073299e1-26d0-4892-a7f1-668a441df51b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.